Effects of the timing of tourniquet release in orthopedic surgery

The impact of timing of tourniquet release on knee range of motion of patients with plating of tibia fractures: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015092824252N1

Enrollment

Registered

2016-05-20

Start date

2016-01-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Fracture. Condition 2: Fracture. Condition 3: Fracture. Fracture of upper end of tibia Fracture of shaft of tibia Fracture of lower end of tibia

Interventions

Intervention 1: Intervention group 1: Cuff of tourniquet will be applied on the most muscular part of the femur before surgery prep. The tourniquet used involves the MICROBACE pneumatic tourniquet sy

Treatment - Surgery

Intervention group 1: Cuff of tourniquet will be applied on the most muscular part of the femur before surgery prep. The tourniquet used involves the MICROBACE pneumatic tourniquet system with the le

Cuff of tourniquet will be applied on the most muscular part of the femur before surgery prep. The tourniquet used involves the MICROBACE pneumatic tourniquet system with the length of 75 cm and width

Eligibility

Sex/Gender

All

Age

18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Age over 18 years and less than 55 years; doing surgery within the first week after fracture; closed and extraarticular tibia fracture; absence of another fracture in any of the limbs; absence of chest, head or abdomen trauma; absence of vascular and nerve damage, the compartment syndrome and a history of previous surgery on the lower limbs; absence of clotting problems, peripheral vascular disease, peripheral neuropathy and pre-operative DVT limb; non-use of steroidal and non-steroidal anti-inflammatory drugs, anticoagulation, chemotherapy, smoking and narcotics; systolic blood pressure less than 20 mm Hg; body mass index less than 30; knee range of motion of more than 135 degrees Exclusion criteria: Tourniquet time greater than 90 minutes; need for re-operation; patient’s reluctance to cooperate in any stage of the study; patient’s death

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Knee Range of Motion. Timepoint: Before surgery, 24 hours and 14 days after surgery. Method of measurement: Goniometer.;Wound healing. Timepoint: preoperatively, 24 hours and 14 days after operation. Method of measurement: REEDA scale.	—

Secondary

Measure	Time frame
Pain. Timepoint: Before surgery, 24 hours and 14 days after surgery. Method of measurement: Visual Analogue Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Khodabakhshi

Birjand University of Medical Sciences

khodabakhshim2013@gmail.com; mkhodabakhshi@bums.ac.ir+98 56 3222 2300

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026